Ayse Hiçsönmez

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Gliosarcomas (GS) are highly malignant and rare tumors of the central nervous system with a poor prognosis. We report here on four patients with GS, the median survival for whom was 9.25 months. Prognosis of GS remains poor, and a multidisciplinary approach (surgery, radiation therapy, and chemotherapy) seems to be associated with slightly more prolonged(More)
  • 1